Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SETD3 - MLL2-depleted epidermal keratinocyte response to the induction of differentiation in vitro
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SETD3 - Protein tyrosine kinase PTK7 knockdown effect on lung adenocarcinoma cell lines
SETD3 - First, second and third trimester pregnancy: maternal cell-free plasma
SETD3 - BET bromodomain inhibitor JQ1 effect on MYC-amplified medulloblastoma cell lines
SETD3 - SMRT depleted breast cancer cell line response to estradiol: time course
SETD3 - Anaplastic thyroid carcinomas: thyroid biopsies
SETD3 - Triple negative breast cancer
SETD3 - Rapamycin-resistant diffuse large B-cell lymphoma cell lines
SETD3 - GRHL3-depleted epidermal keratinocyte response to the induction of differentiation in vitro
SETD3 - Acute Picornavirus-induced exacerbation in asthmatic children: nasal lavage cells
SETD3 - Xenograft ovarian tumor response to anti-cancer therapeutic MT19: time course
SETD3 - Macrophage response to H1N1 and H5N1 influenza viral infections
SETD3 - Epidermal keratinocyte differentiation in vitro
SETD3 - All-trans-retinoic acid effect on transglutaminase 2-silenced, NB4 model of acute promyelocytic leukemia: time course
SETD3 - Staphylococcal alpha-toxin effect on airway epithelial cells
SETD3 - CD138- and CD138+ MACS-sorted myeloma cell lines
SETD3 - Sunitinib effect on renal cancer xenograft tumors
SETD3 - Interleukin-21 effect on STAT3-deficient naïve B cells from autosomal dominant hyper IgE syndrome patients
SETD3 - Oligooxopiperazine effect on hypoxic alveolar adenocarcinoma cell line
SETD3 - Saracatinib-sensitive versus -resistant, PIK3CA mutant colorectal cancer xenografts
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on